MedPath

Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer

Phase 2
Completed
Conditions
Ovarian Cancer
Registration Number
NCT00005051
Lead Sponsor
NYU Langone Health
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have advanced ovarian epithelial cancer.

Detailed Description

OBJECTIVES:

* Determine the toxicity and tolerance of sequential therapy with prolonged

* Determine the response rate and time to progression in this patient

* Determine the relative pharmacokinetics of IV and prolonged oral administration of topotecan in the same patients and compare the pharmacodynamics of topo-1 inhibition when given by IV or oral route.

OUTLINE:

* Regimen A: Patients receive cisplatin IV over 60-90 minutes on day 1 of each course. Topotecan IV is administered continuously on days 1-14 of course 1. Oral topotecan is administered twice daily on days 1-14 for courses 2, 3, and 4. Treatment repeats every 28 days for 4 courses.

* Regimen B: After completion of regimen A, patients receive paclitaxel IV over 3 hours followed by carboplatin IV over 30 minutes on day 1. Treatment repeats every 21 days for 4 courses.

PROJECTED ACCRUAL: A total of 30 patients (15 per arm) will be accrued for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (10)

Albert Einstein Clinical Cancer Center

πŸ‡ΊπŸ‡Έ

Bronx, New York, United States

New York Hospital Medical Center of Queens

πŸ‡ΊπŸ‡Έ

Fresh Meadows, New York, United States

Saint Vincent Catholic Medical Center of New York

πŸ‡ΊπŸ‡Έ

New York, New York, United States

NYU School of Medicine's Kaplan Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

New York, New York, United States

St. Luke's-Roosevelt Hospital Center - Roosevelt Division

πŸ‡ΊπŸ‡Έ

New York, New York, United States

New York Weill Cornell Cancer Center at Cornell University

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Mount Sinai Medical Center, NY

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Herbert Irving Comprehensive Cancer Center at Columbia University

πŸ‡ΊπŸ‡Έ

New York, New York, United States

New York Medical College

πŸ‡ΊπŸ‡Έ

Valhalla, New York, United States

University of Wisconsin Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

Madison, Wisconsin, United States

Albert Einstein Clinical Cancer Center
πŸ‡ΊπŸ‡ΈBronx, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.